1 year return (CAGR)
-49.60%
Fulcrum Therapeutics Inc Exchange (NASDAQ, USD)
FULC
3.80
+0.04 (+1.06%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
-7.36%
5 year return (CAGR)
-32.09%
10 year return (CAGR)
-
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
289.93M
Price/Sales
-
Ent value
254.72M
Price/Book
0.93
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
-15.80%
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 3.80 |
| Daily high | 3.80 |
| Daily low | 3.75 |
| Daily Volume | 731K |
| All-time high | 30.97 |
| 1y analyst estimate | 3.50 |
| Beta | 2.58 |
| EPS (TTM) | -1.11 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | 26 Feb 2026 |
Downside potential
Loading...
Downside potential data
| FULC | S&P500 | |
| Current price drop from All-time high | -87.73% | -0.56% |
| Highest price drop | -92.70% | -56.47% |
| Date of highest drop | 12 Apr 2023 | 9 Mar 2009 |
| Avg drop from high | -63.66% | -10.68% |
| Avg time to new high | 67 days | 12 days |
| Max time to new high | 1256 days | 1805 days |
News
